Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$328K Hold
2,778
0.1% 43
2025
Q4
$292K Sell
2,778
-250
-8% -$23.5K 0.11% 40
2025
Q3
$254K Sell
3,028
-3,662
-55% -$302K 0.09% 48
2025
Q2
$254K Buy
6,690
+3,482
+109% +$277K 0.09% 48
2025
Q1
$288K Hold
3,208
0.12% 43
2024
Q4
$319K Hold
3,208
0.16% 35
2024
Q3
$364K Hold
3,208
0.19% 35
2024
Q2
$397K Hold
3,208
0.17% 37
2024
Q1
$423K Hold
3,208
0.18% 40
2023
Q4
$350K Hold
3,208
0.16% 36
2023
Q3
$330K Hold
3,208
0.18% 33
2023
Q2
$370K Hold
3,208
0.18% 38
2023
Q1
$341K Hold
3,208
0.18% 37
2022
Q4
$356K Buy
+3,208
New +$328K 0.21% 38

Other funds holding MRK

Waterford Advisors's MRK Position: Q1 2026 in Review

Waterford Advisors held its Merck (MRK) position steady in Q1 2026 at 2,778 shares worth $328K. The position accounts for 0.1% of the portfolio, ranked #43.

Waterford Advisors first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $423K in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Waterford Advisors held 2,778 shares of Merck worth $328K as of Q1 2026.
  • Waterford Advisors left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.1% of Waterford Advisors's portfolio in Q1 2026, its #43 holding.
  • Waterford Advisors first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • Waterford Advisors's Merck position peaked at $423K in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Waterford Advisors's 13F filing for Q1 2026, filed 15 May 2026.